International comparison of trends in patients commencing renal replacement therapy by primary renal disease.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Stel, Vianda SAwadhpersad, Ryan
Pippias, Maria
Ferrer-Alamar, Manuel
Finne, Patrik
Fraser, Simon D
Heaf, James G
Hemmelder, Marc H
Martínez-Castelao, Alberto
De Meester, Johan
Palsson, Runolfur
Prischl, Friedrich C
Segelmark, Mårten
Traynor, Jamie P
Santamaria, Rafael
Reisaeter, Anna Varberg
Massy, Ziad A
Jager, Kitty J
Issue Date
2019-10
Metadata
Show full item recordCitation
International comparison of trends in patients commencing renal replacement therapy by primary renal disease. 2019, 24(10):1064-1076Abstract
AIM: To examine international time trends in the incidence of renal replacement therapy (RRT) for end-stage renal disease (ESRD) by primary renal disease (PRD). METHODS: Renal registries reporting on patients starting RRT per million population for ESRD by PRD from 2005 to 2014, were identified by internet search and literature review. The average annual percentage change (AAPC) with a 95% confidence interval (CI) of the time trends was computed using Joinpoint regression. RESULTS: There was a significant decrease in the incidence of RRT for ESRD due to diabetes mellitus (DM) in Europe (AAPC = -0.9; 95%CI -1.3; -0.5) and to hypertension/renal vascular disease (HT/RVD) in Australia (AAPC = -1.8; 95%CI -3.3; -0.3), Canada (AAPC = -2.9; 95%CI -4.4; -1.5) and Europe (AAPC = -1.1; 95%CI -2.1; -0.0). A decrease or stabilization was observed for glomerulonephritis in all regions and for autosomal dominant polycystic kidney disease (ADPKD) in all regions except for Malaysia and the Republic of Korea. An increase of 5.2-16.3% was observed for DM, HT/RVD and ADPKD in Malaysia and the Republic of Korea. CONCLUSION: Large international differences exist in the trends in incidence of RRT by primary renal disease. Mapping of these international trends is the first step in defining the causes and successful preventative measures of CKD.Description
To access publisher's full text version of this article click on the hyperlink belowAdditional Links
https://onlinelibrary.wiley.com/doi/full/10.1111/nep.13531ae974a485f413a2113503eed53cd6c53
10.1111/nep.13531
Scopus Count
Collections
Related articles
- ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
- Authors: Reule S, Sexton DJ, Solid CA, Chen SC, Collins AJ, Foley RN
- Issue date: 2014 Oct
- Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure.
- Authors: Shaw C, Simms RJ, Pitcher D, Sandford R
- Issue date: 2014 Oct
- An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
- Authors: Kramer A, Stel V, Zoccali C, Heaf J, Ansell D, Grönhagen-Riska C, Leivestad T, Simpson K, Pálsson R, Postorino M, Jager K, ERA-EDTA Registry.
- Issue date: 2009 Dec
- Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy.
- Authors: Batista PB, Lopes AA, Costa FA
- Issue date: 2005
- Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.
- Authors: Grace BS, Clayton P, McDonald SP
- Issue date: 2012 Jan